. Determination of optimal DC: NK ratio for co-cultures. IFN-γ levels were measured in DC and NK cell co-cultures established at ratios of 1:1, 1:3 or 1:5. Cocultures were infected in vitro with either type III GBS strain COH-1 or type 2 S. suis strain P1/7 (2.5 × 10 5 CFU, initial DC-bacteria MOI:1). After bacterium-cell contact, antibiotics were added to prevent cell toxicity. Supernatants were collected at 14 h of incubation, and IFN-γ levels were measured by ELISA. Non-stimulated cells (medium alone) served as negative (C−) control. Data represent mean values (in ng/ml) ± SEM of three distinct experiments. *P < 0.05 or **P < 0.01, indicates statistically significant differences between type III GBS and type 2 S. suis strains for the same ratio. 
Supplementary Figure S4. Bacteremia levels in GBS-or S. suis-infected mice after different starting doses of infection. Mice were intraperitoneally infected with different doses of Group B
Streptococcus (GBS) type III strain COH-1 and Streptococcus suis type 2 strain P1/7. Blood samples were collected from the tail at 6 h and 12 h post-infection, and plated onto THB agar plates. Colonies were counted and data expressed as CFU/ml of blood. Clinical signs of septic disease were also recorded, such as depression, swollen eyes, rough hair coat, and lethargy. N = 10-20 mice per group. Figure S5 . Effect of in vivo NK1.1 + cell depletion on GBS or S. suis infection is dose-independent or -dependent, respectively. Mice were either mock-treated or pre-treated with PK-136 monoclonal antibody (mAb) supernatant by 3 injections at days -4, -2 and -1 prior to infection. Twenty-four hours after the last injection (day 0), mice were intraperitoneally infected with different doses of type III GBS wild-type strain COH-1 or of type 2 S. suis wild-type strain P1/7 (n = 10). Survival and levels of bacteremia of infected mice were monitored during 24 h. Blood samples were collected from the tail at 6 h, 12 h, and 24 h post-infection, and plated onto THB agar plates. Colonies were counted and data expressed as CFU/ml of blood. Supplementary Figure S6 . Effect of bacterial capsular polysaccharide (CPS) on cytokine release by DCs in response to S. suis. DCs were stimulated with either type 2 or type 14 S. suis wild-type (WT) strains or their respective non-encapsulated (∆cps) mutants (2.5 x 10 5 CFU, initial MOI:1). After bacterium-cell contact, antibiotics were added to prevent cell toxicity. Nonstimulated cells served as negative control (C-) for basal expression levels. Supernatants were harvested at 14 h of incubation and cytokine production quantified by ELISA. Data are expressed as mean ± SEM (in ng/ml) from eight independent experiments. *P < 0.05 or **P < 0.01, indicates statistically significant differences between WT strains and their respective non-encapsulated mutants.
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